Psychiatric Medication Is in Dire Need of Innovation
Summary by Financial Times
3 Articles
3 Articles
All
Left
Center
1
Right
#Progress in Novel Pharmacotherapies for Mood and Anxiety Disorders Leveraging Lipid Signaling Pathways
The treatment of mood and anxiety disorders continues to present significant challenges, prompting ongoing research into novel therapeutic pathways. Traditional pharmacologic approaches, primarily selective serotonin reuptake inhibitors (SSRIs), have finite efficacy and are often accompanied by adverse effects that can compromise patient adherence. Recent advancements in lipid signaling pathway modulation, particularly through the development of…
A Maison de la santé mentale has opened its doors in the Halles district of Strasbourg. This place is intended to welcome all those who want to learn and exchange about mental disorders.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium